417 related articles for article (PubMed ID: 11808079)
1. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
Yago K; Itoh M; Shimada H
Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation.
Chiang KY; Hazlett LJ; Godder KT; Abhyankar SH; Christiansen NP; van Rhee F; Lee CG; Bridges K; Parrish RS; Henslee-Downey PJ
Bone Marrow Transplant; 2001 Dec; 28(12):1117-23. PubMed ID: 11803352
[TBL] [Abstract][Full Text] [Related]
3. Donor lymphocyte transfusion for the treatment of Epstein-Barr virus-associated lymphoproliferative disorder of the brain.
Nagafuji K; Eto T; Hayashi S; Oshima K; Maeda Y; Gondo H; Inamura T; Niho Y
Bone Marrow Transplant; 1998 Jun; 21(11):1155-8. PubMed ID: 9645581
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-related lymphoproliferative disease complicating childhood acute lymphoblastic leukemia: no recurrence after unrelated donor bone marrow transplantation.
Pondarré C; Kebaili K; Dijoud F; Basset T; Philippe N; Bertrand Y
Bone Marrow Transplant; 2001 Jan; 27(1):93-5. PubMed ID: 11244444
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
6. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
Du B; Li DP; Xu KL; Pan XY
Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
[TBL] [Abstract][Full Text] [Related]
7. [Post-transplant EBV-associated lymphoproliferative disorders--report of two cases].
Iwami H; Misawa A; Tsunamoto K; Kasubuchi Y; Naya M; Hojo M; Goto T; Hibi S; Matsumura T; Todo S; Imashuku S
Rinsho Ketsueki; 1998 Mar; 39(3):198-204. PubMed ID: 9577643
[TBL] [Abstract][Full Text] [Related]
8. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD
Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494
[TBL] [Abstract][Full Text] [Related]
9. Late onset Epstein-Barr virus-associated lymphoproliferative disease after allogeneic bone marrow transplant presenting as breast masses.
Abhyankar SH; Chiang KY; McGuirk JP; Pati AR; Godder KT; Welsh JA; Waldron RL; McElveen JL; Henslee-Downey PJ
Bone Marrow Transplant; 1998 Feb; 21(3):295-7. PubMed ID: 9489654
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia.
Ohga S; Kanaya Y; Maki H; Takada H; Ohshima K; Kanda M; Nomura A; Suminoe A; Matsuzaki A; Hara T
Bone Marrow Transplant; 2000 Jan; 25(2):209-12. PubMed ID: 10673683
[TBL] [Abstract][Full Text] [Related]
11. Unsuccessful CTL transfusion in a case of post-BMT Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD).
Imashuku S; Goto T; Matsumura T; Naya M; Yamori M; Hojo M; Hibi S; Todo S
Bone Marrow Transplant; 1997 Aug; 20(4):337-40. PubMed ID: 9285550
[TBL] [Abstract][Full Text] [Related]
12. Primary central nervous system post-transplant lymphoproliferative disorder presenting as cerebral hemorrhage after unrelated bone marrow transplantation.
Aisa Y; Mori T; Nakazato T; Suzuki S; Suzuki N; Ikeda Y; Okamoto S
Transpl Infect Dis; 2009 Oct; 11(5):438-41. PubMed ID: 19497045
[TBL] [Abstract][Full Text] [Related]
13. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus associated post-transplantation lymphoproliferative disorder with hemophagocytosis in a child with Wiskott-Aldrich syndrome.
Wang IJ; Lu MY; Chiang BL; Lin WC; Lin DT; Lin KH
Pediatr Blood Cancer; 2005 Sep; 45(3):340-3. PubMed ID: 15547918
[TBL] [Abstract][Full Text] [Related]
15. Successful second allogeneic peripheral blood stem cell transplantation and donor lymphocyte infusion in patients with relapsed acute leukemia using the same donors as for the initial allogeneic bone marrow transplantation.
Ishikawa J; Maeda T; Kashiwagi H; Yoshida H; Takahashi I; Kawamoto SI; Yamada M; Kato H; Nishiura T; Tomiyama Y; Matsuzawa Y
Bone Marrow Transplant; 2003 Jun; 31(11):1057-9. PubMed ID: 12774060
[TBL] [Abstract][Full Text] [Related]
16. Effect of in vivo lymphocyte-depleting strategies on development of lymphoproliferative disorders in children post allogeneic bone marrow transplantation.
Lynch BA; Vasef MA; Comito M; Gilman AL; Lee N; Ritchie J; Rumelhart S; Holida M; Goldman F
Bone Marrow Transplant; 2003 Sep; 32(5):527-33. PubMed ID: 12942101
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantation.
Or R; Hadar E; Bitan M; Resnick IB; Aker M; Ackerstein A; Samuel S; Tsirigotis P; Gesundheit B; Slavin S; Shapira MY
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1295-301. PubMed ID: 17162211
[TBL] [Abstract][Full Text] [Related]
18. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
[TBL] [Abstract][Full Text] [Related]
19. Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation.
McGuirk JP; Seropian S; Howe G; Smith B; Stoddart L; Cooper DL
Bone Marrow Transplant; 1999 Dec; 24(11):1253-8. PubMed ID: 10642818
[TBL] [Abstract][Full Text] [Related]
20. Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein-Barr virus load in the peripheral blood of bone marrow transplant recipients.
Liu D; Tammik C; Zou JZ; Ernberg I; Masucci MG; Ringden O; Levitsky V
Clin Transplant; 2004 Oct; 18(5):518-24. PubMed ID: 15344953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
